Evidence map›Paper›PMID 36224501›Full record

ReviewCancer causes & control : CCC2023

Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.

Cary A Presant, Kimlin Ashing, Sophia Yeung, Jonjon Macalintal, Brian Tiep, Argelia Sandoval, Susan Brown, Mary Cianfrocca, Loretta Erhunmwunsee, Dan Raz and 19 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 1 institution in 1 country.

Cary A Presant *City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA. cpresant@coh.org.
Kimlin Ashing *City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.ORCID http://orcid.org/0000-0002-6209-508X
Sophia YeungCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Jonjon MacalintalCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Brian TiepCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Argelia SandovalCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Susan BrownCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Mary CianfroccaCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Loretta ErhunmwunseeCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Dan RazCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Arya AminiCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Ravi SalgiaCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Paul FuCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Amartej MerlaCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Heather GravesCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Ranjan PathakCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Shaira DingalCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Tingting TanCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Kelley TarkeshianCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Liana NikolaenkoCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Kathleen BurnsCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Sagus SampathCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Beverly LaksanaCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Brenda GasconCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Desirae Tainatongo-LandinCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Veronica DegomaCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Shanmuga SubbiahCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Ramnik RaiCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Steven RosenCity of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
City Of Hope National Medical Center · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572NIH HHS P30 CA033572NIH HHS P30 CA033572-37S5
6 · The paper itself

Abstract

backgroundWe designed a process to increase tobacco cessation in an academic center and its widely distributed network community sites using clinical champions to overcome referral barriers.

methodsIn 2020 a needs assessment was performed across the City of Hope Medical Center and its 32 community treatment sites. We reviewed information science strategies to choose elements for our expanded tobacco control plan, focusing on distributed leadership with tobacco cessation champions. We analyzed smoking patterns in patients with cancer before and following program implementation. We evaluated the champion experience and measured tobacco abstinence after 6 months of follow-up.

resultsCancer center leadership committed to expanding tobacco control. Funding was obtained through a Cancer Center Cessation Initiative (C3I) grant. Multi-disciplinary leaders developed a comprehensive plan. Disease-focused clinics and community sites named cessation champions (a clinician and nurse) supported by certified tobacco treatment specialists. Patient, staff, clinician, and champion training/education were developed. Roles and responsibilities of the champions were defined. Implementation in pilot sites showed increased tobacco assessment from 80.8 to 96.6%, increased tobacco cessation referral by 367%, and moderate smoking abstinence in both academic (27.2%) and community sites (22.5%). 73% of champions had positive attitudes toward the program.

conclusionAn efficient process to expand smoking cessation in the City of Hope network was developed using implementation science strategies and cessation champions. This well-detailed implementation process may be helpful to other cancer centers, particularly those with a tertiary care cancer center and community network.

Indexed as

Smoking CessationTobacco Use CessationTobacco Use DisorderHumansImplementation ScienceNicotianaTobacco SmokingCancer Center Cessation InitiativeCertified tobacco treatment specialistsTobacco cessation

Identifiers

PMID36224501
PMCPMC9555700
OpenAlexW4304775814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.